Biomarkers of Acute Kidney Injury in Critical Illness

  • F. Adams
  • B. Venkatesh
Conference paper


In the last decade, epidemiological studies worldwide have shown an increase in the incidence of acute renal failure in critically ill patients [1, 2, 3]. The consequences of renal failure in the critically ill are well recognized. Despite recent advances in renal replacement therapy, the mortality rate from acute renal failure remains high, ranging from 20–50 %. The increased incidence may be due in part to the changing demographic of the critically ill patient. The increasing age of the population, as well as increased co-morbidities, such as hypertension and diabetes mellitus, increase the susceptibility to renal injury. Increasing incidence of sepsis, use of nephrotoxic drugs, and the use of radio contrast media all contribute to the increased likelihood of acute kidney injury (AKI).


Acute Renal Failure Acute Kidney Injury Critical Illness Neutrophil Gelatinase Associate Lipocalin Serum Cystatin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Waikar SS, Curhan GC, Wald R, McCarthy EP Chertow GM (2006) Declining mortality of patients with acute renal failure, 1998 to 2002. J Am Soc Nephrol 17: 1143–1150CrossRefPubMedGoogle Scholar
  2. 2.
    Cole L, Bellomo R, Silvester W, Reeves JH (2000) A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a “closed” ICU. Am J Respir Crit Care Med 162: 191–196PubMedGoogle Scholar
  3. 3.
    Uchino S, Kellum JA, Bellomo R, et al (2005) Acute renal failure in critically ill patients; a multinational, multicentre study JAMA 294: 813–818CrossRefPubMedGoogle Scholar
  4. 4.
    Jo S-K, Xuzhen H, Yuen P, Aslamkhan A, Pritchard J, Dear J, Star R (2004) Delayed DMSO administration protects the kidney from mercuric chloride injury. J Am Soc Nephrol 15: 2648–2654CrossRefPubMedGoogle Scholar
  5. 5.
    Hewitt SM, Dear J, Star R (2004) Discovery of protein biomarkers for renal disease. J Am Soc Nephrol 15: 1677–1689CrossRefPubMedGoogle Scholar
  6. 6.
    Deverajan P, Williams LM (2007) Proteomics for biomarker discovery in acute kidney injury. Semin Nephrol 27: 637–651CrossRefGoogle Scholar
  7. 7.
    Mishra J, Dent C, Tarabishi R, et al (2005) Neutrophil gelatinase associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231–1238CrossRefPubMedGoogle Scholar
  8. 8.
    Wagener G, Jan M, Kim M, et al (2006) Association between increase in urinary neutrophil gelatinase associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anaesthesiology 105: 485–491CrossRefGoogle Scholar
  9. 9.
    Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajn P (2004) Neutrophil gelatinase associated lipocalin:a novel early urinary biomarker for cisplatin nephropathy. Am J Nephrol 24: 307–315CrossRefPubMedGoogle Scholar
  10. 10.
    Mori K, Lee T, Rapoport D, et al (2005) Endocyte delivery of lipocalin-siderophore-iron complex rescues the kidney from ischaemia reperfusion injury. J Clin Invest 115: 610–621PubMedGoogle Scholar
  11. 11.
    Mishra J, Ma Q, Prada A, et al (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischaemic renal injury. J Am Soc Nephrol 14: 2534–2543CrossRefPubMedGoogle Scholar
  12. 12.
    Ding H, He Y, Li K, et al (2007) Urinary Neutrophil gelatinase associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol 123: 227–234CrossRefPubMedGoogle Scholar
  13. 13.
    Mishra J, Ma Q, Kelly C, et al (2006) Kidney NGAL is a novel early biomarker of acute injury following transplantation. Pediatr Nephrol 21: 856–863CrossRefPubMedGoogle Scholar
  14. 14.
    Macdonald J, Marcora S, Jibani M, et al (2006) GFR estimation using cystatin C is not independent of body composition Am J Kidney Dis 48: 712–719CrossRefPubMedGoogle Scholar
  15. 15.
    Herget-Rosenthal S, Marggraf G, Husing J, et al (2004) Early detection of renal failure by cystatin C. Kidney Int 66: 1115–1122CrossRefPubMedGoogle Scholar
  16. 16.
    Delanaye P, Lambermont B, Chapelle J-P, Gielen J, Gerard P, Rorive G. (2004) Plasmatic cystatin c for estimation of glomerular filtration rates in intensive care units. Intensive Care Med 30: 980–983CrossRefPubMedGoogle Scholar
  17. 17.
    Herrero-Morin JD, Malaga S, Fernandez N, et al. (2007) Cystatin C and beta 2 microglobulin: markers of glomerular filtration in critically ill children. Crit Care 11:R59CrossRefPubMedGoogle Scholar
  18. 18.
    Wilhelm SM, Stowe NT, Robinson AV, Schulak JK (2001) The use of the endothelial antagonist lezosentan before or after renal ischaemia protects renal function. Transplantation 71: 211–216CrossRefPubMedGoogle Scholar
  19. 19.
    Muramatsu Y, Tsujie M, Kodha Y, et al (2002) Early detection of cysteine rich protein 61-(CYR61,CCN1) in urine following renal ischaemic reperfusion injury. Kidney Int 62: 1601–1610CrossRefPubMedGoogle Scholar
  20. 20.
    Li B, Hartono C, Ding R, et al (2001) Non invasive diagnosis of renal allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine N Engl J Med 344: 947–954CrossRefPubMedGoogle Scholar
  21. 21.
    Moniaux M, Chakraborty S, Yalniz M, et al (2008) Early diagnosis of pancreatic cancer: neutrophil gelatinase associated lipocalin as a marker of pancreatic intra epithelial neoplasia. Br J Cancer 98 1540–1547CrossRefPubMedGoogle Scholar
  22. 22.
    Lim R, Ahmed N, Borregard V (2007) Neutrophil gelatinase associated lipocalin (NGAL) an early screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor inducedepithelio-mesenchymal transition. Int J Cancer 120: 2426–2434CrossRefPubMedGoogle Scholar
  23. 23.
    Han WK, Alinain A, Wu C-L, et al (2005) Human kidney injury molecule 1 is a tissue and urinary tumour marker of renal cell carcinoma. J Am Soc Nephrol 16: 1126–1134CrossRefPubMedGoogle Scholar
  24. 24.
    Nakai K, Kikuchi M, Fujimoto K, et al (2008) Serum levels of cystatin C in patients with malignancy. Clin Exp Nephrol 12: 132–139CrossRefPubMedGoogle Scholar
  25. 25.
    Tschoeke SK, Oberholzer A, Moldawer L (2006) Interleukin 18:A novel prognostic cytokine in bacteria induced sepsis. Crit Care Med 34: 1225–1233CrossRefPubMedGoogle Scholar
  26. 26.
    Boldt J, Brosch C, Rohn K, Papsdorf M, Mengistu A (2008) Comparison of the effects of gelatin and a modern hydroxyethyl starch on renal function and inflammatory response in elderly cardiac surgical patients. Br J Anaesth 100: 457–464CrossRefPubMedGoogle Scholar
  27. 27.
    Zhou H, Pisitkun T, Aponte A, et al (2006) Exosomal fetuin A identified by proteomics: A novel urinary biomarker for detecting acute kidney injury. Kidney Int 70: 1847–1857CrossRefPubMedGoogle Scholar
  28. 28.
    Reeves B, Kwon W, Ramesh G (2008) Netrin 1 and kidney injury. II Netrin I is an early biomarker of acute kidney injury Am J Physiol Renal Physiol 294:F371–378Google Scholar
  29. 29.
    Coca SG, Peixoto AJ, Garg AV, Krunholz HM, Parikh CR (2007) The prognostic importance of a small acute decrement in kidney function in hospitalised patients: a systematic review and meta analysis. Am J Kidney Dis 50: 712–720CrossRefPubMedGoogle Scholar
  30. 30.
    Westhuyzen J, Endre Z, Reece G, Reith D, Saltissi D, Morgan TJ (2003) Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 18: 534–551CrossRefGoogle Scholar
  31. 31.
    Parikh CR, Mishra J, Thiessen-Philbrook, et al (2006) Urinary IL 18 is an early predictive biomarker of acute kidney injury after cardiac surgery Kidney Int 70: 199–203CrossRefPubMedGoogle Scholar
  32. 32.
    Han WK, Waikar SS, Johnson A, et al (2008) Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int 73: 863–969CrossRefPubMedGoogle Scholar
  33. 33.
    Nickolas TL, O’Rourke MJ, Yang J, et al (2008) Sensitivity and specificity of a single emergency department measurement of urinary Neutrophil Gelatinase Associated Lipocalin for diagnosing acute kidney injury. Ann Intern Med 148: 810–819PubMedGoogle Scholar
  34. 34.
    Ahlstrom A, Tallgren M, Pellonen S, Pettila V (2004) Evolution and predictive power of serum Cystatin C in acute renal failure. Clinical Nephrol 62: 344–350Google Scholar
  35. 35.
    Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL (2005) Urine ILl8 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 16: 3046–3052CrossRefPubMedGoogle Scholar
  36. 36.
    Wheeler DS, Devarajan P, Ma Q, et al (2008) serum neutrophil gelatinase associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 36: 1297–1303CrossRefPubMedGoogle Scholar
  37. 37.
    Washburn KK, Zappitelli M, Arikan AA, et al (2008) Urinary IL18 is an acute kidney injury biomarker in critically ill children. Nephrol Dial Transplant 23: 566–572CrossRefPubMedGoogle Scholar
  38. 38.
    Zappitelli M, Washburn KK, Arikan AA, et al (2007) Urine neutrophil gelatinase associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 11:R84CrossRefPubMedGoogle Scholar
  39. 39.
    Herrero-Morin JD, Malaga S, Fernandez N, et al (2007) Cystatin C and beta 2 microglobulin: marker of glomerular filtration in critically ill children. Crit Care 11:R59CrossRefPubMedGoogle Scholar
  40. 40.
    du Cheyron D, Daubin C, Poggioli J, et al (2003) Urinary measurement of Na+/H+ exchange isoform 3 (NHE3) protein as a new marker of tubule injury in critically ill patients in acute renal failure. Am J Kidney Dis 42: 497–506CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • F. Adams
    • 1
  • B. Venkatesh
    • 1
    • 2
  1. 1.Department of Intensive CarePrincess Alexandra HospitalBrisbaneAustralia
  2. 2.Department of Intensive CareWesley HospitalBrisbaneAustralia

Personalised recommendations